Skip to main content

Advertisement

SpringerLink
Log in

Potential Nutritional Conflicts in Bariatric and Renal Transplant Patients

  • Review
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

An increasing number of morbidly obese patients with end stage renal disease (ESRD) are sequentially undergoing bariatric surgery followed by renal transplantation. Discrepancies between the nutritional recommendations for obesity and chronic kidney disease (CKD) are often confusing for the obese patient in renal failure. However, when recommendations are structured according to stage and treatment of disease, a consistent plan can be clearly communicated to the patient. Therefore, to optimize patient and graft outcomes we present nutritional recommendations tailored to three patient populations: obese patients with ESRD, patients post Roux-en-Y gastric bypass (RYGBP) with ESRD, and patients post RYGBP and post renal transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291(23):2847–50.

    Article  PubMed  CAS  Google Scholar 

  2. Hu FB, Willett WC, Li T, et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694–703.

    Article  PubMed  CAS  Google Scholar 

  3. Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA. 2006;295(2):190–8.

    Article  PubMed  CAS  Google Scholar 

  4. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–6.

    PubMed  CAS  Google Scholar 

  5. Praga M, Hernández E, Andrés A, et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70(1):35–41.

    Article  PubMed  CAS  Google Scholar 

  6. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550–62.

    Article  PubMed  CAS  Google Scholar 

  7. Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33.

    Article  PubMed  CAS  Google Scholar 

  8. Hall JE, Crook ED, Jones DW, et al. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324(3):127–37.

    Article  PubMed  Google Scholar 

  9. Fredrickson SK, Ferro TJ, Schutrumpf AC. Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care. 2004;27(7):1754–5.

    Article  PubMed  Google Scholar 

  10. Morales E, Valero MA, Leon M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003;41(2):319–27.

    Article  PubMed  Google Scholar 

  11. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288(22):2793–6.

    Article  PubMed  Google Scholar 

  12. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg. 2003;13(6):954–64.

    Article  PubMed  Google Scholar 

  13. Palomar R, Fernández-Fresnedo G, Domínguez-Diez A, et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg. 2005;15(6):794–8.

    Article  PubMed  Google Scholar 

  14. Tafti BA, Haghdoost M, Alvarez L, et al. Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery. Obes Surg. 2009;19(9):1335–9.

    Article  PubMed  CAS  Google Scholar 

  15. Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc. 2004;104(3):404–9.

    Article  PubMed  Google Scholar 

  16. Bernhard J, Beaufrère B, Laville M, et al. Adaptive response to a low-protein diet in predialysis chronic renal failure patients. J Am Soc Nephrol. 2001;12(6):1249–54.

    PubMed  CAS  Google Scholar 

  17. Meloni C, Tatangelo P, Cipriani S, et al. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. J Ren Nutr. 2004;14(4):208–13.

    PubMed  Google Scholar 

  18. Feiten SF, Draibe SA, Watanabe R R, et al. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients. Eur J Clin Nutr. 2005;59(1):129–36.

    Article  PubMed  CAS  Google Scholar 

  19. Menon V, Kopple JD, Wang X, et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2009;53(2):208–17.

    Article  PubMed  CAS  Google Scholar 

  20. Mitch WE. Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency. J Am Soc Nephrol. 1991;2(4):823–31.

    PubMed  CAS  Google Scholar 

  21. Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;52(3):778–91.

    Article  PubMed  CAS  Google Scholar 

  22. Castaneda C, Gordon PL, Uhlin KL, et al. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann Intern Med. 2001;135(11):965–76.

    PubMed  CAS  Google Scholar 

  23. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 Suppl 1):S1–S290.

    Google Scholar 

  24. Saha H, Pietilä K, Mustonen J, et al. Acute effects of calcium carbonate and citrate on secondary hyperparathyroidism in chronic renal failure. Am J Nephrol. 1991;11(6):465–9.

    Article  PubMed  CAS  Google Scholar 

  25. Fernandez-Rodriguez AM, Guindeo-Casasus MC, Molero-Labarta T, et al. Diagnosis of iron deficiency in chronic renal failure. Am J Kidney Dis. 1999;34(3):508–13.

    Article  PubMed  CAS  Google Scholar 

  26. Kopelman RC, Smith L, Peoples L, et al. Functional iron deficiency in hemodialysis patients with high ferritin. Hemodial Int. 2007;11(2):238–46.

    Article  PubMed  Google Scholar 

  27. Nissenson AR, Strobos J. Iron deficiency in patients with renal failure. Kidney Int Suppl. 1999;69:S18–21.

    Article  PubMed  CAS  Google Scholar 

  28. Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol. 2010;6(12):699–710.

    Article  PubMed  CAS  Google Scholar 

  29. Jain AK, Bastani B. Safety profile of a high dose ferric gluconate in patients with severe chronic renal insufficiency. J Nephrol. 2002;15(6):681–3.

    PubMed  CAS  Google Scholar 

  30. Whittaker P, Chanderbhan RF. Effect of increasing iron supplementation on blood lipids in rats. Br J Nutr. 2001;86(5):587–92.

    Article  PubMed  CAS  Google Scholar 

  31. Prakash S, Walele A, Dimkovic N, et al. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. Perit Dial Int. 2001;21(3):290–5.

    PubMed  CAS  Google Scholar 

  32. Sharma SK, McCauley J, Cottam D, et al. Acute changes in renal function after laparoscopic gastric surgery for morbid obesity. Surg Obes Relat Dis. 2006;2(3):389–92.

    Article  PubMed  Google Scholar 

  33. Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64. discussion 164–5.

    Article  PubMed  Google Scholar 

  34. Johnson WH, Fernandez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):37–41.

    Article  PubMed  Google Scholar 

  35. Aills L, Blankenship J, Buffington C, et al. ASMBS allied health nutritional guidelines for the surgical weight loss patient. Surg Obes Relat Dis. 2008;4(5 Suppl):S73–S108.

    Article  PubMed  Google Scholar 

  36. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis. 2008;4(5 Suppl):S109–84.

    Article  PubMed  Google Scholar 

  37. Ello-Martin JA, Roe LS, Ledikwe JH, et al. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr. 2007;85(6):1465–77.

    PubMed  CAS  Google Scholar 

  38. Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89(3):1061–5.

    Article  PubMed  CAS  Google Scholar 

  39. Ybarra J, Sánchez-Hernández J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;15(3):330–5.

    Article  PubMed  Google Scholar 

  40. Mechanick JI, Kushne RF, Sugerman HJ, et al. Executive summary of the recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14(3):318–36.

    PubMed  Google Scholar 

  41. Nasr SH, D’ Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3(6):1676–83.

    Article  PubMed  Google Scholar 

  42. Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010;211(1):8–15.

    Article  PubMed  Google Scholar 

  43. Tucker ON, Szomstein S, Rosenthal RJ. Nutritional consequences of weight-loss surgery. Med Clin North Am. 2007;91(3):499–514. xii.

    Article  PubMed  CAS  Google Scholar 

  44. Vargas-Ruiz AG, Hernandez-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):288–93.

    Article  PubMed  Google Scholar 

  45. Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008;248(5):714–20.

    PubMed  Google Scholar 

  46. Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6(2):357–63.

    Article  PubMed  CAS  Google Scholar 

  47. Micozkadioglu H, Ozdemir FN, Sezer S, et al. Weight gain after living-related renal transplantation affects long-term graft function. Transplant Proc. 2005;37(2):1029–32.

    Article  PubMed  CAS  Google Scholar 

  48. Meier-Kriesche HU, Vaghela M, Thambuganipalle R, et al. The effect of body mass index on long-term renal allograft survival. Transplantation. 1999;68(9):1294–7.

    Article  PubMed  CAS  Google Scholar 

  49. Pirsch JD, Armbrust JM, Knechtle SJ, et al. Obesity as a risk factor following renal transplantation. Transplantation. 1995;59(4):631–3.

    PubMed  CAS  Google Scholar 

  50. Cheung CY, Chan YH, Chan HW, et al. Optimal body mass index that can predict long-term graft outcome in Asian renal transplant recipients. Nephrology. 2010;15(2):259–65.

    Article  PubMed  Google Scholar 

  51. Teplan V, Poledne R, Scück O, et al. Hyperlipidemia and obesity after renal transplantation. Ann Transplant. 2001;6(2):21–3.

    PubMed  CAS  Google Scholar 

  52. Arthur JM, Shamim S. Interaction of cyclosporine and FK506 with diuretics in transplant patients. Kidney Int. 2000;58(1):325–30.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, Stanford University School of Medicine, MSLS, 3rd Floor, MC: 5492, 1201 Welch Road, Stanford, CA, 94305-5102, USA

    Amy L. Lightner, James Lau, Patricia Obayashi, Kristine Birge & Marc L. Melcher

  2. Department of Surgery, University of California at Los Angeles, Los Angeles, CA, USA

    Amy L. Lightner

Authors
  1. Amy L. Lightner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kristine Birge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marc L. Melcher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amy L. Lightner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lightner, A.L., Lau, J., Obayashi, P. et al. Potential Nutritional Conflicts in Bariatric and Renal Transplant Patients. OBES SURG 21, 1965–1970 (2011). https://doi.org/10.1007/s11695-011-0423-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-011-0423-0

Keywords

Search

Navigation